Gufic Biosciences has received permission from the Central Drugs Standard Control Organization, Ministry of Health And Family Welfare, New Delhi to manufacture and market Liposomal Amphotericin B Injection 50mg/vial (Lyophilized), subject to the conditions prescribed in Chapter X of the New Drugs and Clinical Trials Rules, 2019 under the Drugs and Cosmetics Act, 1940.
The said injection is used to treat cases of Mucormycosis, also called as Black Fungus that damages the nose, eyes, sinuses, and sometimes even the brain. Mucormycosis is a very rare infection which is caused by exposure to mucor mould which is commonly found in soil, plants, manure, and decaying fruits and vegetables and it affects the sinuses, the brain and the lungs and can be life-threatening in diabetic or severely immunocompromised individuals, such as cancer patients or people with HIV/AIDS.
Gufic Biosciences is engaged in diversified business viz. Pharma, Healthcare, Bio- Technology, Seeds, Herbal etc.
